INIS
patients
100%
diseases
57%
antibodies
56%
kidneys
28%
neutrophils
24%
inflammation
22%
therapy
22%
control
20%
complement
14%
risks
12%
comparative evaluations
12%
biopsy
9%
levels
9%
adults
9%
hypertension
8%
coronaviruses
7%
interstitials
7%
evaluation
7%
induction
7%
cyclophosphamide
6%
covid-19
6%
lungs
6%
immunoglobulins
6%
data
6%
genetics
6%
plasma
5%
spectra
5%
proteins
5%
Keyphrases
ANCA-associated Vasculitis
28%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
23%
Antineutrophil Cytoplasmic Antibody
22%
Immune-mediated Inflammatory Diseases
12%
Thrombotic Microangiopathy
11%
Granulomatosis with Polyangiitis
11%
COVID-19
9%
Microscopic Polyangiitis
7%
Immunosuppressive Therapy
7%
Vaccination
7%
Disease Activity
7%
Healthy Controls
6%
Rituximab
6%
Breakthrough Infection
6%
Remission
6%
Proteinase 3
5%
MPO-ANCA
5%
Antibody-associated
5%
Renal Vasculitis
5%
Risk Factors
5%
Cyclophosphamide
5%
Remission Induction
5%
Vasculitis
5%
Dilated Cardiomyopathy
5%
Medicine and Dentistry
ANCA Associated Vasculitis
18%
Neutrophil Cytoplasmic Antibody
18%
Microangiopathy
11%
Disease
9%
Granulomatosis with Polyangiitis
7%
Immunity
7%
Vasculitis
7%
Glomerulonephritis
7%
Myeloblastin
6%
Myocardial Disease
6%
Diagnosis
6%
Microscopic Polyangiitis
5%
Immunosuppressive Treatment
5%
Cohort Analysis
5%